Name
CE Session: Molecular Testing for Non-Small Cell Lung Cancer
Date & Time
Friday, October 28, 2022, 5:05 PM - 6:05 PM
Speakers
Description
Description: This session will overview indications for genomic testing for lung cancer, including specific considerations for tumor versus liquid biopsy. The role of the Molecular Tumor Board and the pharmacists role in reviewing and interpreting next generation sequencing will be discussed as well as applications for the selection of therapy. Key concepts will be illustrated with case presentations.
Speaker: Jill Kolesar, PharmD, BCOP, University of Kentucky
Location Name
Osceola CD
Full Address
Gaylord Palms Resort & Convention Center
6000 W Osceola Pkwy
Kissimmee, AZ 34746
United States
6000 W Osceola Pkwy
Kissimmee, AZ 34746
United States
Session Type
General Session